{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&min-dateTabled=2014-11-25&tablingMemberConstituency=Blaydon&max-dateTabled=2015-01-13", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?answeringDeptShortName=Health&min-dateTabled=2014-11-25&tablingMemberConstituency=Blaydon&max-dateTabled=2015-01-13", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&min-dateTabled=2014-11-25&tablingMemberConstituency=Blaydon&max-dateTabled=2015-01-13&_metadata=all", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&_page=0&min-dateTabled=2014-11-25&tablingMemberConstituency=Blaydon&max-dateTabled=2015-01-13", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&min-dateTabled=2014-11-25&tablingMemberConstituency=Blaydon&max-dateTabled=2015-01-13", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&min-dateTabled=2014-11-25&tablingMemberConstituency=Blaydon&max-dateTabled=2015-01-13", "items" : [{"_about" : "http://data.parliament.uk/resources/173274", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/173274/answer", "answerText" : {"_value" : "

All staff will receive an increase in their take home pay this year either as a result of an incremental pay increase or as a result of a 1% pay increase.<\/p>

<\/p>

Trade unions know we are willing to discuss any affordable proposals that could end the pay dispute.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"} } , "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"} , "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"} , "dateOfAnswer" : {"_value" : "2015-01-13", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-01-13T15:10:36.55Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-01-07", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "NHS: Pay"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what steps he is taking to resolve the pay dispute in the NHS.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1486", "label" : {"_value" : "Biography information for Mr David Anderson"} } , "tablingMemberConstituency" : {"_value" : "Blaydon"} , "tablingMemberPrinted" : [{"_value" : "Mr David Anderson"} ], "uin" : "906975"} , {"_about" : "http://data.parliament.uk/resources/171632", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/171632/answer", "answerText" : {"_value" : "

Since 1 April 2013, NHS England has been responsible for commissioning specialised neurological services, which includes services for patients with neuromuscular disorders. NHS England has published a service specification for neurological care, which sets out what providers must have in place to offer evidence-based, safe and effective services. The specification can be found at the following link:<\/p>

<\/p>

<\/p>

<\/p>

www.england.nhs.uk/wp-content/uploads/2013/06/d04-neurosci-spec-neuro.pdf<\/a><\/p>

<\/p>

<\/p>

<\/p>

Specialised neuromuscular care may include referral to local or specialised physiotherapy, hydrotherapy or rehabilitation if appropriate. Provision of hydrotherapy services is a matter for the local National Health Service and may be accessed by patients with neuromuscular and other long-term debilitating conditions, subject to assessment and referral.<\/p>

<\/p>

<\/p>

<\/p>

Neuromuscular patients may also be referred for enabling equipment such as wheelchairs adaptations and environmental controls in line with their clinical commissioning group or specialist rehabilitation referral criteria, subject to the complexity of need.<\/p>

<\/p>

<\/p>

<\/p>

NHS England is currently undertaking a review of wheelchair services, led by Rosamond Roughton, National Director of Commissioning Development, which will consider provision across both specialised and non-specialised wheelchairs.<\/p>

<\/p>

<\/p>

<\/p>

NHS England has set up strategic clinical networks (SCNs) for neurological conditions to provide clinical expertise and guidance. Alongside SCNs, Operational Delivery Networks (ODNs) are working with commissioners, providers and patients to ensure the delivery of safe and effective services across the patient pathway and help secure the best outcomes for all people with neurological conditions. Providers are at liberty to set up an ODN for neuromuscular services if they consider it would benefit service provision locally.<\/p>

<\/p>

<\/p>

<\/p>

<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1439", "label" : {"_value" : "Biography information for Norman Lamb"} } , "answeringMemberConstituency" : {"_value" : "North Norfolk"} , "answeringMemberPrinted" : {"_value" : "Norman Lamb"} , "dateOfAnswer" : {"_value" : "2015-01-09", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "219448"} , {"_value" : "219449"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-01-09T13:55:53.95Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-12-18", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Hydrotherapy"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what steps his Department and NHS England are taking to increase the number and availability of hydrotherapy pools for people living with (a) neuromuscular and (b) other long-term debilitating conditions.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1486", "label" : {"_value" : "Biography information for Mr David Anderson"} } , "tablingMemberConstituency" : {"_value" : "Blaydon"} , "tablingMemberPrinted" : [{"_value" : "Mr David Anderson"} ], "uin" : "219488"} , {"_about" : "http://data.parliament.uk/resources/171633", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/171633/answer", "answerText" : {"_value" : "

Since 1 April 2013, NHS England has been responsible for commissioning specialised neurological services, which includes services for patients with neuromuscular disorders. NHS England has published a service specification for neurological care, which sets out what providers must have in place to offer evidence-based, safe and effective services. The specification can be found at the following link:<\/p>

<\/p>

<\/p>

<\/p>

www.england.nhs.uk/wp-content/uploads/2013/06/d04-neurosci-spec-neuro.pdf<\/a><\/p>

<\/p>

<\/p>

<\/p>

Specialised neuromuscular care may include referral to local or specialised physiotherapy, hydrotherapy or rehabilitation if appropriate. Provision of hydrotherapy services is a matter for the local National Health Service and may be accessed by patients with neuromuscular and other long-term debilitating conditions, subject to assessment and referral.<\/p>

<\/p>

<\/p>

<\/p>

Neuromuscular patients may also be referred for enabling equipment such as wheelchairs adaptations and environmental controls in line with their clinical commissioning group or specialist rehabilitation referral criteria, subject to the complexity of need.<\/p>

<\/p>

<\/p>

<\/p>

NHS England is currently undertaking a review of wheelchair services, led by Rosamond Roughton, National Director of Commissioning Development, which will consider provision across both specialised and non-specialised wheelchairs.<\/p>

<\/p>

<\/p>

<\/p>

NHS England has set up strategic clinical networks (SCNs) for neurological conditions to provide clinical expertise and guidance. Alongside SCNs, Operational Delivery Networks (ODNs) are working with commissioners, providers and patients to ensure the delivery of safe and effective services across the patient pathway and help secure the best outcomes for all people with neurological conditions. Providers are at liberty to set up an ODN for neuromuscular services if they consider it would benefit service provision locally.<\/p>

<\/p>

<\/p>

<\/p>

<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1439", "label" : {"_value" : "Biography information for Norman Lamb"} } , "answeringMemberConstituency" : {"_value" : "North Norfolk"} , "answeringMemberPrinted" : {"_value" : "Norman Lamb"} , "dateOfAnswer" : {"_value" : "2015-01-09", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "219449"} , {"_value" : "219488"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-01-09T13:55:53.813Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-12-18", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Neuromuscular Disorders"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what plans he has to develop more regional managed clinical neuromuscular networks.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1486", "label" : {"_value" : "Biography information for Mr David Anderson"} } , "tablingMemberConstituency" : {"_value" : "Blaydon"} , "tablingMemberPrinted" : [{"_value" : "Mr David Anderson"} ], "uin" : "219448"} , {"_about" : "http://data.parliament.uk/resources/171634", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/171634/answer", "answerText" : {"_value" : "

Since 1 April 2013, NHS England has been responsible for commissioning specialised neurological services, which includes services for patients with neuromuscular disorders. NHS England has published a service specification for neurological care, which sets out what providers must have in place to offer evidence-based, safe and effective services. The specification can be found at the following link:<\/p>

<\/p>

<\/p>

<\/p>

www.england.nhs.uk/wp-content/uploads/2013/06/d04-neurosci-spec-neuro.pdf<\/a><\/p>

<\/p>

<\/p>

<\/p>

Specialised neuromuscular care may include referral to local or specialised physiotherapy, hydrotherapy or rehabilitation if appropriate. Provision of hydrotherapy services is a matter for the local National Health Service and may be accessed by patients with neuromuscular and other long-term debilitating conditions, subject to assessment and referral.<\/p>

<\/p>

<\/p>

<\/p>

Neuromuscular patients may also be referred for enabling equipment such as wheelchairs adaptations and environmental controls in line with their clinical commissioning group or specialist rehabilitation referral criteria, subject to the complexity of need.<\/p>

<\/p>

<\/p>

<\/p>

NHS England is currently undertaking a review of wheelchair services, led by Rosamond Roughton, National Director of Commissioning Development, which will consider provision across both specialised and non-specialised wheelchairs.<\/p>

<\/p>

<\/p>

<\/p>

NHS England has set up strategic clinical networks (SCNs) for neurological conditions to provide clinical expertise and guidance. Alongside SCNs, Operational Delivery Networks (ODNs) are working with commissioners, providers and patients to ensure the delivery of safe and effective services across the patient pathway and help secure the best outcomes for all people with neurological conditions. Providers are at liberty to set up an ODN for neuromuscular services if they consider it would benefit service provision locally.<\/p>

<\/p>

<\/p>

<\/p>

<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1439", "label" : {"_value" : "Biography information for Norman Lamb"} } , "answeringMemberConstituency" : {"_value" : "North Norfolk"} , "answeringMemberPrinted" : {"_value" : "Norman Lamb"} , "dateOfAnswer" : {"_value" : "2015-01-09", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "219448"} , {"_value" : "219488"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-01-09T13:55:53.627Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-12-18", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Neuromuscular Disorders"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what steps he is taking to ensure that sufficient funding is available for wheelchair services for neuromuscular patients with complex needs.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1486", "label" : {"_value" : "Biography information for Mr David Anderson"} } , "tablingMemberConstituency" : {"_value" : "Blaydon"} , "tablingMemberPrinted" : [{"_value" : "Mr David Anderson"} ], "uin" : "219449"} , {"_about" : "http://data.parliament.uk/resources/167088", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/167088/answer", "answerText" : {"_value" : "

A number of potential areas are being considered for new national clinical audits, including asthma. However, no final decision has yet been taken.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2014-12-08", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-12-08T15:09:37.387Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-12-01", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Asthma"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, if he will work with NHS England to ensure that a national clinical audit is carried out into services for people with asthma.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1486", "label" : {"_value" : "Biography information for Mr David Anderson"} } , "tablingMemberConstituency" : {"_value" : "Blaydon"} , "tablingMemberPrinted" : [{"_value" : "Mr David Anderson"} ], "uin" : "216563"} , {"_about" : "http://data.parliament.uk/resources/166019", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/166019/answer", "answerText" : {"_value" : "

The Government is committed to ensuring that patients have access to new and effective treatments, including those which may extend life, on terms that represent value to the National Health Service and the taxpayer.<\/p>

<\/p>

<\/p>

<\/p>

The National Institute for Health and Care Excellence (NICE) is the independent body responsible for providing advice to the NHS on the clinical and cost-effectiveness of health technologies. NHS commissioners are legally required to fund treatments recommended by NICE technology appraisal guidance, ensuring consistent access to clinically and cost effective drugs across England. NICE has introduced greater flexibility in the appraisal of effective drugs for patients at the end of their lives, which has helped to secure patient access to a number of potentially life-extending drugs.<\/p>

<\/p>

<\/p>

<\/p>

We are commissioning an external review of the pathways for the development, assessment, and adoption of innovative medicines and medical technology. This review will consider how to speed up access for NHS patients to cost-effective new diagnostics, medicines and devices.<\/p>

<\/p>

<\/p>

<\/p>

<\/strong><\/p>

<\/p>

<\/strong><\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"} } , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"} , "answeringMemberPrinted" : {"_value" : "George Freeman"} , "dateOfAnswer" : {"_value" : "2014-12-02", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-12-02T14:07:57.967Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-11-25", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "NHS: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what steps he is taking to ensure that the NHS provides fair access for all to life-extending drugs; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1486", "label" : {"_value" : "Biography information for Mr David Anderson"} } , "tablingMemberConstituency" : {"_value" : "Blaydon"} , "tablingMemberPrinted" : [{"_value" : "Mr David Anderson"} ], "uin" : "215834"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 6, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }